Researchers identify tumor microenvironment of metastasis (TMEM) that allows breast cancer to metastasize

Using real-time, high-resolution imaging, scientists have identified how a doorway in the blood vessel wall allows cancer cells to spread from breast tumors to other parts of the body. The findings lend support to emerging tests that better predict whether breast cancer will metastasize, which could spare women from invasive and unnecessary treatments, and could lead to new anticancer therapies. These findings were published in Cancer Discovery (2015; doi:10.1158/2159-8290.CD-15-0012).

The research utilized a mouse model of human breast cancer and mice implanted with human breast tissue. Investigators at the National Cancer Institute-designated Albert Einstein Cancer Center (AECC) and Montefiore Einstein Center for Cancer Care in Bronx, New York, conducted the study.

The researchers previously found that breast cancer spreads when three specific cells are in direct contact: an endothelial cell (cells that line the blood vessels), a perivascular macrophage (immunes cell found near blood vessels), and a tumor cell that produces high levels of Mena (a protein that enhances a cancer cell's ability to invade). The site where these three cells come in direct and stable contact, which is called a tumor microenvironment of metastasis (TMEM), is where tumor cells enter blood vessels.

"It has been known for some time that blood vessels in tumors are abnormally permeable. But what regulates that permeability hasn't been clear. Based on our latest imaging studies, we can now say that this phenomenon is regulated by TMEM macrophages," said lead author Allison Harney, PhD, Bridge Postdoctoral Fellow in the Integrated Imaging Program at Albert Einstein College of Medicine.

This new research indicates that the TMEM macrophage releases a protein called vascular endothelial growth factor (VEGF) that causes a local increase in blood vessel permeability. The effect is temporary but can last long enough to allow cancer cells to enter the blood stream. This allows cells to escape the primary tumor and travel to distant sites.

The researchers also observed for the first time that transient blood vessel permeability and tumor cell entry into the bloodstream occur simultaneously and exclusively at TMEM sites. The discovery was made using intravital high-resolution two-photon microscopy to image primary breast cancer tumors in mice and human xenografts (human breast cancer tissue grafted into mice).

"The discovery of a unique doorway that allows tumor cells into the blood stream opens new opportunities for the development of antimetastasis therapeutics" said study leader John Condeelis, PhD, professor and co-chair of anatomy and structural biology, co-director of the Gruss Lipper Biophotonics Center and the Integrated Imaging Program, and the Judith and Burton P. Resnick Chair in Translational Research at Einstein and leader of the Tumor Microenvironment and Metastasis Program at AECC.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs